Skip to main content
. 2024 Apr 3;11:1376319. doi: 10.3389/fmed.2024.1376319

Table 2.

Identification of CNVs in different groups of NT measurement.

NT (mm) Numerical abnormalities of chromosomes P/LP CNVs VUS CNVs Normal Total
Total Trisomy-21 Trisomy-18 Trisomy-13 monosomy-X Other
<2.5 2 (0.8) 0 (0.0) 1 (0.4) 0 (0.0) 0 (0.0) 1 (0.4) 3 (1.1) 20 (7.6) 237 (90.5) 262
2.5–2.9 12 (4.1) 8 (2.7) 1 (0.3) 1 (0.3) 0 (0.0) 2 (0.7) 15 (5.1) 24 (8.2) 242 (82.6) 293
3.0–3.4 42 (7.5) 23 (4.1) 7 (1.3) 4 (0.7) 3 (0.5) 5 (0.9) 29 (5.2) 30 (5.4) 457 (81.9) 558
3.5–4.4 82 (13.6) 49 (8.1) 10 (1.7) 6 (1.0) 5 (0.8) 12 (2.0) 26 (4.3) 43 (7.1) 451 (74.9) 602
4.5–5.4 42 (16.5) 19 (7.5) 9 (3.5) 4 (1.6) 5 (2.0) 5 (2.0) 22 (8.7) 16 (6.3) 174 (68.5) 254
5.5–6.4 41 (32.0) 14 (10.9) 7 (5.5) 4 (3.1) 10 (7.8) 6 (4.7) 6 (4.7) 6 (4.7) 75 (58.6) 128
≥6.5 90 (51.4) 9 (5.1) 27 (15.4) 2 (1.1) 51 (29.1) 1 (0.6) 13 (7.4) 6 (3.4) 66 (37.7) 175
Total 311 (13.7) 122 (5.4) 62 (2.7) 21 (0.9) 74 (3.3) 32 (1.4) 114 (5.0) 145 (6.4) 1702 (74.9) 2,272
χ2 trend 275.11 22.33 84.00 217.58 8.60 3.35 184.84
p-value <0.0001 <0.0001 <0.0001 <0.0001 <0.05 >0.05 <0.0001

P/LP CNVs, pathogenic/likely pathogenic copy number variations; VUS CNV, variant of uncertain significance copy number variations.